July 22, 2026
3 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
MONTREAL — Suprachoroidal triamcinolone acetonide had a durable effect in patients with chronic cystoid macular edema, according to a real-world study.In his presentation at the American Society of Retina Specialists annual meeting, Sunir J. Garg, MD, FACS, FASRS, said Xipere (triamcinolone acetonide injectable suspension, Bausch + Lomb) was approved for uveitic macular edema 5 years ago,
July 22, 2026
3 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

CG-P5, a topical peptide eye drop, met safety and efficacy endpoints for wet age-related macular degeneration, according to a…

MONTREAL — Pegcetacoplan may help slow visual acuity loss in patients with geographic atrophy, according to a study presented at…

Pegcetacoplan slows photoreceptor and retinal pigment epithelium loss in patients with geographic atrophy only as well as…

LAS VEGAS — A VEGF/Ang-2 inhibitor demonstrated faster drying compared with faricimab in patients with diabetic macular edema,…

FORT LAUDERDALE, Fla. — An intravitreal insert provides durable control of multiple retinal diseases, according to a presentation…

WASHINGTON — Cyclodialysis performed with modern ab interno approaches should not be discounted as a treatment option for…